LIFE PHARMA-DETOX PROJECT
Demonstration of an innovative method for the detoxification of pharmaceutical wastewater from pharmaceutical facilities. This project aims to the development and implementation of an innovative, economically viable and cost-efficient system for the transformation of pharmaceutical compounds, present in wastewater, into non-toxic substances. In this way, the environmental impacts occurring due to poor controlled discharge of APIs in the wastewater sewage system will be eliminated.

Latest News
LIFE PHARMA-DETOX Layman’s Report is here! The LIFE PHARMA-DETOX project demonstrates how pharmaceutical wastewater can be transformed from an environmental challenge into a valuable resource, supporting cleaner water, circular water use and better regulatory preparedness for the pharmaceutical industry. In LIFE PHARMA-DETOX Layman’s Report, you will find an overview of the pilot system and its...
The project is co-funded by LIFE, the EU’s financial instrument supporting environmental, nature conservation and climate action projects throughout the EU. Our Project is also part of the LIFE projects that are co-Funded by the Green Fund. The project team would like to thank the Green Fund for co-funding the NTUA activities. More specifically, according...
The LIFE PHARMA-DETOX project was presented at ECOMED EXPO, where its innovative approach to pharmaceutical wastewater treatment and its environmental impact were showcased to industry professionals, researchers, and institutional stakeholders.
LIFE PHARMA-DETOX
The project is co-funded by LIFE
The project is co-funded by LIFE, the EU’s financial instrument supporting environmental, nature conservation and climate action projects throughout the EU.
Our Project is also part of the LIFE projects that are co-Funded by the Green Fund. The project team would like to thank the Green Fund for co-funding the NTUA activities. More specifically, according to the Decision Number 242.4/2022 of the Management Board of the Green Fund, the amount of 60,000 Euro was approved for the year 2022.







